The supplementation of the HFD with BAE amplified intestinal but not hepatic FXR expression, suggesting that alterations in bile acid signaling in the gut played a pivotal role in mediating its anti-obesity action. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.